10-1074 - National Institute of Allergy and Infectious Diseases, Rockefeller University, Gilead
3BNC117 - Rockefeller University, Cornell University, Frontier Biotech, Gilead
https://programme.aids2026.org/Abstract/DesktopAbstractDetail/?abstractid=7912
 
C. Nel1; T. Tipoe1,2; J. Edgar1; P. Zacharopoulou1; M. Lee3; L.-R. Cherrill4; E. Falaschetti4; H. Box4,5; T. Elliott3,5; S. Kinloch6; J. Fox7; A. Clarke8; S. Pett9; S. Collins10; M.B. Balachandran3; K. Topping3; L. Terry7; K. Seaton11; G. Tomaras11; A. Uriel12; C. Orkin13; G. Whitlock14; M. Boffito14; R. Sutherland15; H. Brown1; N. Robinson1; P. Goulder16; M. Caskey17; M. Nussenzweig17,18; S. Fidler3,5; J. Frater1,19; The RIO Study Team
 
May 3, 2026
 
Prev Next